Yeasen Biotechnology at the 5th Annual mRNA-Based Therapeutics Summit

About the Summit

The 5th Annual mRNA-Based Therapeutics Summit is the premier international event for mRNA innovation, uniting 500+ leaders from biotech, pharma, and academia. The 2025 summit will spotlight the latest breakthroughs in:

  • mRNA design and engineering

  • IVT process optimization and dsRNA reduction

  • Novel delivery systems and capping strategies

  • Scalable GMP manufacturing

Event Details

📅 Date: July 21–23, 2025
đź“Ť Location: Boston, MA, USA
🎯 Booth: Visit us at Booth 5

Come meet the Yeasen team to explore how our advanced solutions can support your mRNA therapeutic programs from discovery to GMP production.

Featured Products

LZCap™ AG(3’Acm) (GMP-Grade, High Affinity Cap1 Analog)

Designed for enhanced translation and expression

  • >97% capping efficiency

  • Strong eIF4E binding for improved translation

  • Higher protein output vs. traditional Cap1 analogs

  • Stabilized mRNA for therapeutic durability

An ideal choice for high-yield IVT and clinical mRNA applications.

Hieff™ T7 RNA Polymerase (Low dsRNA)

Engineered to minimize dsRNA without compromising yield

  • >10Ă— lower dsRNA content

  • No need for additional dsRNA removal steps

  • Reduced innate immunogenicity, in vitro and in vivo

  • Fully compatible with Cap1 analogs, including LZCap™ AG(3’Acm)

A robust solution for high-purity, low-immunogenicity mRNA synthesis.

Why Visit Booth 5?

✔️ Free giveaways
✔️ In-depth technical consultations with our R&D team
✔️ Discover how Yeasen can accelerate your mRNA pipeline

Let’s shape the next generation of mRNA therapeutics—together.

 

Want to Learn More?

Can’t attend the summit? We’ve got you covered.
đź“© Contact us or request a sample today.

Website: www.yeasenbio.com
Email: info@yeasenbio.com

 

Additional Information

For more details, visit 5th Annual mRNA-Based Therapeutics Summit.

 

Förfrågan